Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADAP | INAB | CYCN | ||
| Company | Adaptimmune Ther ADR | In8Bio Inc | Cyclerion Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.0666 | 1.4900 | 3.02 | ||
| High | 0.0701 | 1.6100 | 3.30 | ||
| Low | 0.0526 | 1.4900 | 3.02 | ||
| Latest | 0.0549 | 1.6100 | 3.26 | ||
| Change | -0.0098 | +0.1100 | unch | ||
| % Change | -15.15% | +7.33% | unch | ||
| Volume | 50,777,800 | 76,686 | 77,974 | ||
| 20-Day Average Volume | 127,153,055 | 62,597 | 371,676 | ||
| Previous Close | 0.0647 | 1.5000 | 3.26 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.1355 | 1.4645 | 3.08 | ||
| 20-Day Raw Stochastic | 5.66% | 96.67% | 34.25% | ||
| 20-Day Relative Strength | 40.90 | 51.77 | 56.71 | ||
| Weighted Alpha | -58.21 | -55.28 | -46.96 | ||
| Today's Opinion | 88% Sell | 72% Sell | 88% Buy | ||
| Previous Opinion | 88% Sell | 88% Sell | 88% Buy | ||
| Last Month's Opinion | 56% Sell | 100% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.95% since 10/20/25 | +2.56% since 04/27/26 | +10.99% since 04/27/26 | ||
| Low | 0.0417 on 10/21/25 | 1.4400 on 04/30/26 | 2.83 on 04/28/26 | ||
| High | 0.0926 on 10/22/25 | 1.6000 on 05/04/26 | 3.50 on 04/29/26 | ||
| 1-Month | |||||
| %Chg | -62.65% since 09/26/25 | +11.11% since 04/02/26 | -47.12% since 04/02/26 | ||
| Low | 0.0417 on 10/21/25 | 1.3100 on 04/15/26 | 2.79 on 04/08/26 | ||
| High | 0.2750 on 10/09/25 | 1.6100 on 04/27/26 | 5.45 on 04/06/26 | ||
| 3-Month | |||||
| %Chg | -84.17% since 07/25/25 | -18.37% since 02/04/26 | +162.26% since 02/04/26 | ||
| Low | 0.0403 on 09/08/25 | 1.3100 on 04/15/26 | 1.03 on 02/09/26 | ||
| High | 0.2750 on 10/09/25 | 2.1100 on 03/16/26 | 8.48 on 04/01/26 | ||
| 6-Month | |||||
| %Chg | -79.31% since 04/25/25 | -3.03% since 11/04/25 | +92.43% since 11/04/25 | ||
| Low | 0.0403 on 09/08/25 | 1.1700 on 12/19/25 | 1.03 on 02/09/26 | ||
| High | 0.3578 on 07/24/25 | 2.7300 on 01/16/26 | 8.48 on 04/01/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,551 | 14,771 | 14,117 | ||
| Shares Outstanding, K | 265,052 | 9,847 | 4,330 | ||
| Annual Sales | 178,030,000 | 0 | 2,070,000 | ||
| Annual Net Income | -70,810,000 | -19,440,000 | -3,530,000 | ||
| Last Quarter Sales | 13,680,000 | 0 | 1,030,000 | ||
| Last Quarter Net Income | -30,340,000 | -4,940,000 | -800,000 | ||
| 60-Month Beta | 2.49 | 0.08 | 1.80 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 08/13/25 | -0.26 on 03/12/26 | -0.19 on 03/30/26 | ||
| Earnings Date | 11/12/25 | 05/06/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||